BDX Becton Dickinson and Company

   By Kimberly Chin 
 

Becton, Dickinson and Co. (BDX) swung to a profit in the first fiscal quarter compared with a year ago as sales were lifted primarily due to its acquisition of C.R. Bard.

The medical technology company's net income was $599 million, or $2.05 a share, compared with a loss of $136 million, or 76 cents a share a year ago. Analysts polled by Refinitiv were expecting earnings of $1.41 a share.

On an adjusted basis, the company reported per-share earnings of $2.70, compared with consensus estimates of $2.61.

Revenue rose 35% to $4.16 billion from a year earlier. Analysts expected $4.11 billion.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

February 05, 2019 06:37 ET (11:37 GMT)

Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Aug 2024 to Sep 2024

Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Sep 2023 to Sep 2024